"Drugs, Generic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
| Descriptor ID |
D016568
|
| MeSH Number(s) |
D26.360
|
| Concept/Terms |
Drugs, Generic- Drugs, Generic
- Drugs, Nonproprietary
- Nonproprietary Drugs
- Generic Drugs
|
Below are MeSH descriptors whose meaning is more general than "Drugs, Generic".
Below are MeSH descriptors whose meaning is more specific than "Drugs, Generic".
This graph shows the total number of publications written about "Drugs, Generic" by people in this website by year, and whether "Drugs, Generic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drugs, Generic" by people in Profiles.
-
Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal. J Am Board Fam Med. 2019 Nov-Dec; 32(6):807-817.
-
Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States. Value Health. 2019 07; 22(7):762-767.
-
The introduction of generic risperidone in Medicare Part D. Am J Manag Care. 2016 Jan; 22(1):41-8.
-
Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):488-95.
-
Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study. J Am Geriatr Soc. 2010 May; 58(5):822-8.
-
Effect of generic-only drug benefits on seniors' medication use and financial burden. Am J Manag Care. 2006 Sep; 12(9):525-32.
-
Successful conversion of patients with hypercholesterolemia from a brand name to a generic cholesterol-lowering drug. Am J Manag Care. 2005 Sep; 11(9):546-52.
-
Financial consequences of drug benefit plans. JAMA. 2003 Jan 22-29; 289(4):423; author reply 424.